Physician profile
Timothy Siebecker
NPI 1184651762
$3,485.60
in general payments reported to CMS, 2019-2025
13 companies · $736 in 2025
The $736 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2022: $222 · 2023: $895 · 2024: $1,365 · 2025: $736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,784 · Travel and Lodging: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,784.20 |
| Travel and Lodging | $1,211.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $858.06 | 2024 | |
| Arthrex, INC. | $485.80 | 2023 | |
| Stryker Corporation | $410.55 | 2019-2022 | |
| Smith+Nephew, INC. | $405.49 | 2019-2025 | Oasis, Stravix Pl, Grafix Pl |
| Novus Surgical Consultants | $326.84 | 2023-2025 | |
| Heron Therapeutics, INC. | $250.00 | 2023-2025 | Zynrelef, Aponvie |
| Abbott Laboratories | $178.04 | 2025 | Proclaim |
| Organogenesis INC. | $138.03 | 2024 | |
| Boston Scientific Corporation | $133.43 | 2024 | |
| Paratek Pharmaceuticals, INC. | $125.01 | 2024 | Nuzyra |
| Depuy Synthes Sales INC. | $110.10 | 2024 | Motoband |
| Orthofix Medical, INC. | $40.67 | 2025 | Physio-Stim |
| Solventum Corporation | $23.58 | 2025 | Prevena, V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Siebecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.